Cardiac arrhythmia – Communicable Diseases Research

Education of Patients With Atrial Fibrillation and Evaluation of the Efficacy of a Mobile Virtual Patient Environment: Protocol for a Multicenter Pseudorandomized Controlled Trial

Protocol

Published on 2024-01-232024-09-05
Journal: JMIR Research Protocols [Category] update2024,

From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021/22

Article

Published on 2022-10-212022-11-15
Journal: Cardiovascular Research [Category] 바이오마커, 유전자 메커니즘,

Acute cardiac side effects after COVID-19 mRNA vaccination: a case series

COVID-19 mRNA 백신 접종 후 급성 심장 부작용: 사례 시리즈

Case Reports

Published on 2022-06-022022-09-11
Journal: European Journal of Medical Research [Category] COVID19(2023년), SARS, 변종,

[키워드] affecting age analyzed approval Asymptomatic BNT162b2 cardiac adverse event cardiac adverse events Cardiac arrhythmia Case series case sery CDC criteria chest pain clinical Clinical data clinical information Containment COVID-19 defined determined by Diagnosis Dyspnea eight Electrocardiography elevated female females Germany healthy individuals Hospitalization Host Infection Inflammation Information System inoculation magnetic resonance imaging male males Mild Moderna MRI mRNA mRNA vaccination mRNA vaccine mrna-1237 mRNA-1273 myocarditis occur onset of symptoms organ damage pandemic pathophysiology Patient patients Pericarditis Registered reported required retrieved risk factor Risk factors SARS-CoV-2 second dose severe cases severity Side effect Support Symptom symptom onset the disease the vaccine troponin troponin levels vaccination Vaccine variants viral mutation was performed
[DOI] 10.1186/s40001-022-00695-y PMC 바로가기 [Article Type] Case Reports

SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells

SARS-CoV-2 감염은 동방결절 박동조율기 세포의 페롭토시스를 유도합니다

Article

Published on 2022-04-012022-09-11
Journal: Circulation research [Category] COVID19(2023년), SARS, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 bradycardia candidate drug candidate drugs Cardiac arrhythmia cardiac arrhythmias cause Cell cells Chain Reaction characterized clinical feature coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Deferoxamine detect determine difficulty disease drug drug candidates dysfunction embryonic stem cell Evidence exposure to Express Ferroptosis functional hamsters heart hearts host response identify Imatinib immunostaining Increasing induce Infection inhibit SARS-CoV-2 marker MYH6 node pacemaker pacemaker cell pacemaker cells pathophysiology patients with COVID-19 polymerase chain polymerase chain reaction potential mechanism PROTECT Protein Quantitative Quantitative real-time polymerase chain reaction reporter RNA RNA sequencing RNA, viral SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus SHOX2 Single-cell RNA sequencing Sinoatrial sinoatrial node Sinus sinus node Spike protein stem cells Viral RNA was performed were used
[DOI] 10.1161/CIRCRESAHA.121.320518 PMC 바로가기 [Article Type] Article

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Covid-19 (회복)로 병원에 입원 한 환자의 Casirivimab 및 Imdevimab : 무작위, 통제, 오픈 라벨, 플랫폼 시험

Randomized Controlled Trial

Published on 2022-02-122022-08-13
Journal: Lancet (London, England) [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, 치료제,

[키워드] (Medical Research Council 1:1 28-day mortality 95% CI Administered Adverse reaction Adverse reactions All participants all randomly assigned patients all-cause mortality Analysis antibody assigned baseline baseline antibody status bleeding Cardiac arrhythmia Casirivimab cause-specific mortality clinically suspected Combination death detectable died dose Efficacy Efficacy and safety eligible Eligible participants enrolled evaluate finding funding hospital host cells humoral immune response Imdevimab Innovation Intention intention to treat intravenous infusion investigator investigators ISRCTN laboratory-confirmed SARS-CoV-2 infection Local major bleeding events Medical Research Council monoclonal antibody monoclonal antibody combination Mortality mounted non-competing monoclonal antibodies non-competing monoclonal antibody Open-label outcome p value participant Patient Platform trial Primary outcome randomisation randomised randomised, controlled, open-label platform trial Randomly randomly assigned patient rate ratio Receptor binding domain recovery reduced Registered reported Safety SARS-COV-2 infection SARS-CoV-2 spike glycoprotein SARS-CoV-2 vaccine Serious adverse reactions seronegative seronegative patient seronegative patients seropositive seropositive and seronegative patients Seven significantly single intravenous infusion spike glycoprotein Standard of care the SARS-CoV-2 thrombosis Treatment Trial UK hospital usual care usual care alone Viral viral entry with COVID-19
[DOI] 10.1016/S0140-6736(22)00163-5 PMC 바로가기 [Article Type] Randomized Controlled Trial

Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems

Physiology

Published on 2022-01-142022-10-31
Journal: Frontiers in Physiology [Category] COVID-19,

[키워드] ACE2 ACE2 receptor acute respiratory syndrome age aging angiotensin-converting enzyme 2 cardiac Cardiac arrhythmia cardiac arrhythmias cardiac complication Cardiac complications cardiovascular comorbidities cardiovascular condition cardiovascular disease case fatality rates complications complications of COVID-19 condition conditions coronavirus cough COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients Critical case damaged de novo diabetes dysregulation elderly endothelial cells evaluate expressed expression Fever Glia greater highest Hypercoagulation hypertension improve clinical outcome in-depth analysis incidence include increased risk Infection Interaction ischemic heart disease manifestation mechanism mortality risk Myocardial Myocardial infarction Neuron Neuropathy oxygen supply pandemic Patient patients presenting symptom Prognosis prognostic indicator reduce reported risk risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 patient SARS-CoV-2 patients SARS-CoV2 Shortness of breath shown System systemic hyper-inflammation the SARS-CoV-2 tissue vasculature virus
[DOI] 10.3389/fphys.2021.748972 PMC 바로가기 [Article Type] Physiology

Cardiac Arrhythmias and COVID-19: Correlation With Disease Severity

Cardiology

Published on 2021-12-182022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] 95% CI ACE-I African American age Analysis angiotensin-converting enzyme inhibitor arrhythmia Arrhythmias association Atrial fibrillation baseline characteristics blocker cardiac Cardiac arrhythmia cardiac arrhythmias cardiovascular complication CCI Comorbidity coronavirus disease correlation COVID-19 death demographic characteristics diagnoses disease severity electrical evaluate had more HFNC hospitalized COVID-19 patient incidence Invasive mechanical ventilation Laboratory life-threatening male nasal New Older Oxygen requirement Patient patients hospitalized patients who survived patients with arrhythmia Poisson regression positive airway pressure positively correlated receptor recruited reported Result retrospective risk significantly higher the patient therapy USA Ventilation was used with COVID-19
[DOI] 10.7759/cureus.20507 PMC 바로가기 [Article Type] Cardiology

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

Research

Published on 2021-12-142022-10-05
Journal: Nature Medicine [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료기술,

Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment

Review

Published on 2021-11-182022-10-31
Journal: The Egyptian Heart Journal [Category] COVID-19,

Heart-rate-variability (HRV), predicts outcomes in COVID-19

심박수 변동성(HRV), COVID-19의 결과 예측

Research Article

Published on 2021-10-282022-09-12
Journal: PLoS ONE [Category] MERS, SARS, 진단,

[키워드] Admission adverse outcome adverse outcomes Asymptomatic disease bpm bradycardia Cardiac arrhythmia cardiac arrhythmias clinical manifestations consecutive patient COVID-19 COVID-19 infection death determine diagnosed ECG examined greater heart rate Hospitalization Hospitalized HRV ICU immune response independent independent of Inflammation intensive care intensive care unit interval marker median value Mild Mortality Older outcome pacemaker Patient patients hospitalized predict predicted Premature Premature contractions Previous studies previous study Prognostic factors Prognostic value protective role recorded Result retrospective cohort study risk Standard deviation survival Tachycardia vagus nerve variety ventricular with COVID-19 younger patients
[DOI] 10.1371/journal.pone.0258841 PMC 바로가기 [Article Type] Research Article